WINTON GROUP Ltd grew its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 113.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 12,475 shares of the medical instruments supplier’s stock after buying an additional 6,639 shares during the quarter. WINTON GROUP Ltd’s holdings in DENTSPLY SIRONA were worth $746,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also recently modified their holdings of the company. Commonwealth Bank of Australia raised its holdings in DENTSPLY SIRONA by 19.0% in the second quarter. Commonwealth Bank of Australia now owns 1,626 shares of the medical instruments supplier’s stock worth $104,000 after purchasing an additional 260 shares during the period. Acrospire Investment Management LLC acquired a new stake in shares of DENTSPLY SIRONA during the second quarter worth $113,000. Dupont Capital Management Corp bought a new position in DENTSPLY SIRONA in the second quarter valued at $116,000. Massey Quick Simon & CO. LLC bought a new position in DENTSPLY SIRONA in the third quarter valued at $124,000. Finally, Korea Investment CORP grew its position in DENTSPLY SIRONA by 139.9% in the second quarter. Korea Investment CORP now owns 2,145 shares of the medical instruments supplier’s stock valued at $139,000 after purchasing an additional 1,251 shares in the last quarter. 96.58% of the stock is currently owned by hedge funds and other institutional investors.

Shares of DENTSPLY SIRONA Inc. (XRAY) opened at $65.50 on Thursday. DENTSPLY SIRONA Inc. has a one year low of $52.53 and a one year high of $68.98. The company has a quick ratio of 1.59, a current ratio of 2.32 and a debt-to-equity ratio of 0.21. The stock has a market cap of $15,069.50, a price-to-earnings ratio of 26.14, a PEG ratio of 2.60 and a beta of 1.31.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a negative net margin of 20.33% and a positive return on equity of 7.56%. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $978.99 million. During the same quarter in the prior year, the business posted $0.66 EPS. The business’s revenue was up 5.8% compared to the same quarter last year. research analysts expect that DENTSPLY SIRONA Inc. will post 2.66 earnings per share for the current year.

A number of analysts have recently issued reports on XRAY shares. BidaskClub cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research note on Wednesday, August 16th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Cleveland Research lowered shares of DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a report on Thursday, October 5th. Barrington Research raised shares of DENTSPLY SIRONA from a “market perform” rating to an “outperform” rating and set a $73.00 target price on the stock in a report on Monday, November 6th. Finally, Morgan Stanley reaffirmed an “overweight” rating and issued a $69.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Friday, October 6th. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company’s stock. DENTSPLY SIRONA has a consensus rating of “Hold” and an average price target of $67.73.

In other DENTSPLY SIRONA news, Director Francis J. Lunger sold 8,900 shares of the stock in a transaction dated Monday, November 13th. The shares were sold at an average price of $65.90, for a total transaction of $586,510.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Nicholas W. Alexos bought 50,000 shares of the business’s stock in a transaction on Monday, November 13th. The shares were acquired at an average price of $65.85 per share, with a total value of $3,292,500.00. The disclosure for this purchase can be found here. 1.99% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: “DENTSPLY SIRONA Inc. (XRAY) Shares Bought by WINTON GROUP Ltd” was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another website, it was copied illegally and republished in violation of U.S. and international copyright law. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/12/07/dentsply-sirona-inc-xray-shares-bought-by-winton-group-ltd.html.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.